At the present time, 430 drugs are known to cause respiratory injury. This represents an increase of almost 200 in the last ten years, and the number is still increasing. This comprehensive, definitive reference work with an outstanding range of international expert contributors and two of the world’s leading editors, provides an essential reference for the practising respiratory physician.
Key features:

• The text builds upon basics with a review of basic sciences.
• The book covers imaging, varied drug-induced interstitial lung disease including pulmonary edema and diffuse alveolar hemorrhage, acute respiratory failure, pleural involvement and upper to lower airway disease
• A wide range of diseases are detailed from chemotherapy and radiation to biologic induced lung disease, drug misuse, and special groups such as recipients of stem cell and solid organ transplants.
• A range of world class contributions from key opinion leaders.

This book provides essential information for recognizing and managing drug-induced respiratory disease for all pulmonologists and respiratory care physicians. It will be of great interest to: critical care medicine specialists, hematologists, oncologists, cardiologists, allergists, rheumatologists, neurologists, internists, blood-bank specialists, pathologists and primary care physicians.

* Builds upon basics with a review of basic sciences.
* The book covers imaging, interstitial disease, chest symptoms and respiratory failure
* A wide range of diseases are detailed from chemotherapy and radiation to drug misuse, the respiratory effects of neurological drugs and special groups such as pediatric drug-induced respiratory disease
* A range of world class contributions from key opinion leaders


Table of Contents:
1. Introduction
2. Drug-induced respiratory disease: classification, diagnosis, and management
3. Mechanisms in respiratory toxicology
4. Imaging of Drug-induced Lung Disease
5. Bronchoalveolar Lavage in Drug Induced Lung Disease
6. Pathology of drug-induced respiratory disease
7. Drug Allergy in Lung Disease
I - DRUG-INDUCED RESPIRATORY EMERGENCIES
8. Drug-induced upper-airway obstruction
9. Drug-induced bronchospasm
10. Drug-induced Pulmonary Edema and Acute Respiratory Distress Syndrome
11 Pulmonary complications of Blood Transfusion
12. Drug-Induced Alveolar Hemorrhage
13. Pulmonary complications of illicit drug use
14. Iatrogenic tracheobronchial and chest injury
II - ONCOLOGY AND ALLIED CONDITIONS
15. The “chemotherapy lung”
16. Pulmonary Reactions Due to Novel Chemotherapeutic Agents and Biomolecules
17. Radiation-induced Lung Disease
18. Pulmonary complications of bone marrow and stem cell transplantation
19. Pulmonary complications of solid organ transplantation
20. Drug-induced pulmonary infection
21. Therapy-induced neoplasms
III - NONONCOLOGIC CONDITIONS
22. Drug-induced pneumonitis induced by noncytotoxic agents
23. Amiodarone pulmonary toxicity
24. Drug-induced eosinophilic pneumonia
25. Drug-Induced and Radiotherapy Bronchiolitis Obliterans Organizing Pneumonia (BOOP)”
26. Drug-induced cough
27. Drug-induced pleural disease
28. Drug-induced lupus erythematosus syndrome
29. Drug-induced- vasculitis
30. Drug- and toxin-induced pulmonary hypertension
32. Respiratory involvement from herbals

About the Author(s):
Philippe Camus, MD is Professor of Pulmonary Medicine, Department of Pulmonary and Critical Care Medicine, Hôpital du Bocage and Université de Bourgogne, Dijon, France
Edward C Rosenow III, MD, MS, MACP, Master FCCP is Emeritus Professor of Medicine, Former Chair Division of Pulmonary and Critical Care Medicine, Mayo Distinguished Clinician, Mayo Clinic School of Medicine, Rochester, Minnesota, USA